Physician profile
James D Day
NPI 1235316886
$1,179.03
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $477 · 2020: $548 · 2021: $20.44 · 2022: $54.99 · 2023: $79.20.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $79.20.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $79.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endologix LLC | $913.52 | 2019-2020 | |
| Braintree Laboratories, INC. | $53.32 | 2019 | |
| Innocoll Pharmaceuticals Limited | $39.32 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $23.45 | 2023 | Andexxa |
| Merck Sharp & Dohme LLC | $21.49 | 2023 | |
| Smith+Nephew, INC. | $21.08 | 2019 | |
| Z-Medica, LLC | $20.26 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $19.76 | 2022 | |
| Boston Scientific Corporation | $17.94 | 2023 | Spyglass |
| Merit Medical Systems INC | $16.35 | 2022 | |
| Tela Bio, INC. | $16.32 | 2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Shire North American Group INC | $16.22 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Day listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.